Filter Results:
(281)
Show Results For
- All HBS Web
(417)
- News (88)
- Research (281)
- Events (1)
- Multimedia (4)
- Faculty Publications (96)
Show Results For
- All HBS Web
(417)
- News (88)
- Research (281)
- Events (1)
- Multimedia (4)
- Faculty Publications (96)
Sort by
- 23 Mar 2003
- Research & Ideas
AIDS in Africa—What’s the Solution?
5th Annual Africa Business Conference at Harvard Business School on March 8. Much of the debate over AIDS in Africa has surrounded the high cost of the drugs that have turned the deadly disease into one that... View Details
Keywords: by Julie Jette
- 30 May 2007
- Research & Ideas
Health Care Under a Research Microscope
system had been brought to the table. That's all changing now, and the major players seem increasingly receptive to rethinking the system. He points to the Medicare Drug Prescription Plan, launched in 2006,... View Details
- 19 Sep 2017
- First Look
First Look at New Research and Ideas, September 19
https://www.hbs.edu/faculty/Pages/item.aspx?num=53199 forthcoming Industrial and Corporate Change Toward a Prescriptive Theory of Dynamic Capabilities: Connecting Strategic Choice, Learning, and Competition By: Pisano, Gary P. Abstract—The... View Details
Keywords: Sean Silverthorne
- 09 Aug 2016
- First Look
August 9, 2016
spending in the United States, accounting for less than 1% of prescriptions filled but nearly 28% of drug spending. Whereas traditional (chemically synthesized, "small-molecule") View Details
Keywords: Sean Silverthorne
- 17 Sep 2001
- Research & Ideas
Is There Help for the Big Ticket Buyer?
helping individuals make wise consumption decisions. Behavioral decision researchers in consumer research have used the rationality criterion to demonstrate consumer bias, but this descriptive research typically has not been applied View Details
Keywords: by Max H. Bazerman
- 10 Sep 2008
- Research & Ideas
Long-Tail Economics? Give Me Blockbusters!
by focusing on bigger films that require a bigger commitment." Jeff Robinov believes in blockbusters and his strategy is to create more of them. The pharmaceutical and entertainment industries are similar. R&D costs in both are... View Details
- 27 Jun 2005
- Research & Ideas
The Potential Downside of Win-Win
consideration for all managers. Value Creation—and Collusion Suppose that pharmaceutical firm A manufactures a new, beneficial drug and begins selling 100 million pills per year at $3.05 per pill. Each pill View Details
Keywords: by Max H. Bazerman
- 15 Jan 2018
- Research & Ideas
A Better Business Model for Fighting Cancer
benefits of sharing data, which can then be used to more quickly identify the most pressing targets and design trials to address them. Innovations to the typical clinical trial model are also being used. In an adaptive platform trial, for example, different View Details
- 17 Sep 2001
- Research & Ideas
Why E-commerce Didn’t Die With the Fall of Webvan
drugs for chronic conditions—from pharmacies to a combination of direct mail and telephone. The idea was that if you have a chronic condition, you're in a replenishment mode. You have to fill the View Details
- 07 Aug 2000
- Research & Ideas
The Business of Biotech
will give way to $200 to $300 million drugs. That will be a very different world for big drug companies, with different cost structures and resource-allocation processes." And the View Details
- 16 Oct 2013
- Op-Ed
Response to Readers: Combating Climate Change with Nuclear Power and Fracking
With more than 7,500 views and 180-plus tweets, I want to thank everyone for taking the time to read the original HBS Working Knowledge piece, The Case for Combating Climate Change with Nuclear Power and Fracking, and, in particular, for sharing your thoughts with one... View Details
- 13 Jul 2009
- Research & Ideas
Diagnosing the Public Health Care Alternative
think the chances of a government plan supplanting private options are slim," he writes. But the existence of both public and private insurance plans might provide enough competition to improve overall value for patients. Professor Michael Porter cautions that a public... View Details
- 12 Jul 2006
- Research & Ideas
Competition the Cure for Healthcare
the various actors in the system are not designed around value, nor is competition reinforcing improvements in value. For example, let's take the prescription drug benefit, the big reform of today that... View Details
- 23 Dec 2014
- First Look
First Look: December 23
Abstract—Negotiation analysis seeks to develop prescriptive theory and useful advice for negotiators and third parties. It generally emphasizes the parties' underlying interests, alternatives to negotiated agreement, approaches to... View Details
Keywords: Carmen Nobel
- 13 Jan 2003
- Research & Ideas
Making Biotech Work as a Business
around seventy months in 2002. The length of time it takes to develop a drug is obviously a major driver of the cost of developing the drug, Pisano said. "The productivity of R&D biotech is... View Details
- 29 May 2001
- Research & Ideas
How Technological Disruption Changes Everything
could only be accomplished by specialists in less convenient, centralized settings. PCs, for example, brought computing power to individuals at a fraction of the cost of minicomputers, replacing the minicomputer specialist and centralized... View Details
- 07 Apr 2003
- Research & Ideas
Three Steps for Crisis Prevention
South Africa over its attempt to reduce the cost of HIV drugs through parallel importation (buying pharmaceuticals in countries with lower prices and then importing them) and compulsory licensing (requiring... View Details
Keywords: by Michael D. Watkins & Max H. Bazerman
- 16 May 2011
- Research & Ideas
What Loyalty? High-End Customers are First to Flee
service quality are more or less immune from the high-end challenger. These findings suggest that before mounting a counterattack on a competitor's incursion, it's important to understand your customer priorities and your business's place along the service View Details
Keywords: by Julia Hanna
- 26 Jun 2000
- Research & Ideas
What’s an Internet Business Model? Ask a Health Care Professional
either." CareGroup, as an "integrated delivery group," gives patients and physicians within the network an ability to conduct a myriad of activities online. These tasks can range from refilling prescriptions to accessing personal MRI... View Details
- 12 Jan 2016
- First Look
January 12, 2016
November–December 2015 Operations Research Active Postmarketing Drug Surveillance for Multiple Adverse Events By: Goh, Joel, Margrét V. Bjarnadóttir, Mohsen Bayati, and Stefanos A. Zenios Abstract—Postmarketing View Details
Keywords: Carmen Nobel